NEW YORK, May 5, 2014 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of ABIOMED, Inc. ("ABIOMED" or the "Company") (NasdaqGS: ABMD). The investigation focuses on whether the Company and its executives violated federal securities laws.
On May 1, 2014, Company announced in a press release that "on April 25, 2014, ABIOMED received a subpoena from the Boston regional office of the United States Department of Health and Human Services, Office of Inspector General requesting materials relevant to the Company's reimbursement of expenses and remuneration to healthcare providers during the period of July 2012 – December 2012. The Office of Inspector General has informed the Company that the subpoena currently relates to a civil investigation."
On this news, shares of ABIOMED fell $1.32, or more than 5.57%, on intraday trading to $22.37, on unusually heavy trading volume.
If you are aware of any facts relating to this investigation, or purchased shares of ABIOMED you can assist this investigation by contacting either Peretz Bronstein or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email email@example.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman 212-697-6484
SOURCE Bronstein, Gewirtz & Grossman, LLC